PANAYOTOPOULOU, Effrosini G., MÜLLER, Anna-Katharina, BÖRRIES, Melanie, BUSCH, Hauke, HU, Guohong und LEV, Sima, 2019. Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells. Freiburg: Universität.
Elsevier - Harvard (with titles)Panayotopoulou, E.G., Müller, A.-K., Börries, M., Busch, H., Hu, G., Lev, S., 2019. Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells. Universität, Freiburg. https://doi.org/10.18632/oncotarget.15125
American Psychological Association 7th editionPanayotopoulou, E. G., Müller, A.-K., Börries, M., Busch, H., Hu, G., & Lev, S. (ca. 2019). Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells [Cd]. Universität. https://doi.org/10.18632/oncotarget.15125
Springer - Basic (author-date)Panayotopoulou EG, Müller A-K, Börries M, Busch H, Hu G, Lev S (2019) Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Panayotopoulou, Effrosini G./ Müller, Anna-Katharina/ Börries, Melanie/ Busch, Hauke/ Hu, Guohong/ Lev, Sima, Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells, Freiburg 2019.